Kazia Therapeutics: Raises $4.5m and launches SPP
Kazia Therapeutics Raises $4.5m and launches SPPKazia Therapeutics (KZA) launches $4.5 million via a placement to drive its clinical program toward several critical...
Kazia Therapeutics: Partners with DFCI to treat rare lymphoma
Cancer treatment specialist Kazia Therapeutics (KZA) is teaming up with the U.S. Dana-Farber Cancer Institute (DFCI) to treat a rare type of lymphoma
...

